Smith Anglin Financial’s CNS Pharmaceuticals CNSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$32.7K	–	200
2024 Q1	$32.7K	Buy	3 +1	+50%	+$10.9K	﹤0.01%	197
2023 Q4	$63.5K	Buy	+2	New	+$63.5K	0.01%	180